Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D. Indian pharma... ...http://www.rediff.com/money/report/big-pharmas-mega-plan-to-beat-competition-in-us/20170220.htm
The demand for biosimilars is bound to increase with more complex biologics going off-patent ...http://www.business-standard.com/article/companies/indian-biosimilar-market-likely-to-touch-1-billion-in-three-years-117021900424_1.html
Amid mostly muted global cues, the Indian stock market stayed quite sluggish during the week ended 17 February 2017. Quarterly results from India... ...http://www.sify.com/finance/weekly-wrap-sensex-nifty-eke-out-modest-gains-news-sensex-rctkELfaejbbb.html
AI systems are also being used for litigations involving US federal patent cases with great success ...http://www.business-standard.com/article/current-affairs/how-ai-may-become-a-game-changer-for-the-indian-legal-industry-117021800722_1.html
Posted by Equitymaster Asian equity markets are under pressure today as Chinese and Hong Kong indices opened lower. The Shanghai Composite is off... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/P8en8CBcYcQ/tm.asp
Palaniappan Srinivasan received M.Sc....